Annual EBIT
-$150.77 M
-$177.28 M-668.92%
01 December 2023
Summary:
Sinovac Biotech annual earnings before interest & taxes is currently -$150.77 million, with the most recent change of -$177.28 million (-668.92%) on 01 December 2023. During the last 3 years, it has fallen by -$368.84 million (-169.14%). SVA annual EBIT is now -100.86% below its all-time high of $17.65 billion.SVA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
N/A
01 June 2024
Summary:
Sinovac Biotech quarterly earnings before interest & taxes is not available.SVA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
N/A
01 June 2024
Summary:
Sinovac Biotech TTM earnings before interest & taxes is not available.SVA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SVA EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -169.1% | - | - |
| 5 y5 years | -416.4% | - | - |
SVA EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.9% | at low | ||||
| 5 y | 5 years | -100.9% | at low | ||||
| alltime | all time | -100.9% | at low |
Sinovac Biotech EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$150.77 M(-668.9%) | - | - |
| Dec 2022 | $26.50 M(-99.8%) | - | - |
| Dec 2021 | $17.57 B(+7955.2%) | - | - |
| Dec 2020 | $218.07 M(+205.1%) | $198.69 M(+626.6%) | $218.07 M(+344.4%) |
| Sept 2020 | - | $27.34 M(>+9900.0%) | $49.07 M(+34.7%) |
| June 2020 | - | $272.00 K(-103.3%) | $36.43 M(-37.1%) |
| Mar 2020 | - | -$8.24 M(-127.8%) | $57.89 M(-19.0%) |
| Dec 2019 | $71.47 M(+50.0%) | $29.69 M(+102.0%) | $71.47 M(+67.5%) |
| Sept 2019 | - | $14.70 M(-32.4%) | $42.67 M(-5.1%) |
| June 2019 | - | $21.73 M(+307.1%) | $44.95 M(+19.6%) |
| Mar 2019 | - | $5.34 M(+498.5%) | $37.58 M(-21.1%) |
| Dec 2018 | $47.65 M(+2.2%) | $892.00 K(-94.7%) | $47.65 M(+1.9%) |
| Sept 2018 | - | $16.98 M(+18.2%) | $46.76 M(+57.0%) |
| June 2018 | - | $14.37 M(-6.8%) | $29.78 M(+93.2%) |
| Mar 2018 | - | $15.41 M(+53.9%) | $15.41 M(+1054.3%) |
| Dec 2017 | $46.61 M(+3391.6%) | - | - |
| Dec 2016 | $1.33 M(-71.4%) | $10.01 M(+62.0%) | $1.33 M(-122.2%) |
| Sept 2016 | - | $6.18 M(-145.4%) | -$6.01 M(-54.5%) |
| June 2016 | - | -$13.60 M(+981.2%) | -$13.23 M(-368.6%) |
| Mar 2016 | - | -$1.26 M(-147.2%) | $4.93 M(+5.4%) |
| Dec 2015 | $4.68 M(-18.7%) | $2.67 M(-357.0%) | $4.67 M(-32.3%) |
| Sept 2015 | - | -$1.04 M(-122.8%) | $6.91 M(-26.3%) |
| June 2015 | - | $4.56 M(-401.9%) | $9.38 M(+246.3%) |
| Mar 2015 | - | -$1.51 M(-130.8%) | $2.71 M(-52.9%) |
| Dec 2014 | $5.75 M(-53.7%) | $4.90 M(+242.4%) | $5.75 M(-33.5%) |
| Sept 2014 | - | $1.43 M(-167.7%) | $8.65 M(-20.7%) |
| June 2014 | - | -$2.11 M(-237.5%) | $10.90 M(-30.6%) |
| Mar 2014 | - | $1.54 M(-80.3%) | $15.70 M(+26.0%) |
| Dec 2013 | $12.44 M(-166.0%) | $7.79 M(+111.7%) | $12.46 M(+6242.0%) |
| Sept 2013 | - | $3.68 M(+37.0%) | $196.50 K(-102.4%) |
| June 2013 | - | $2.69 M(-257.9%) | -$8.04 M(-40.5%) |
| Mar 2013 | - | -$1.70 M(-61.9%) | -$13.51 M(-29.9%) |
| Dec 2012 | -$18.86 M(-473.4%) | -$4.47 M(-1.8%) | -$19.28 M(+153.9%) |
| Sept 2012 | - | -$4.56 M(+63.7%) | -$7.59 M(+39.1%) |
| June 2012 | - | -$2.78 M(-62.7%) | -$5.46 M(-636.3%) |
| Mar 2012 | - | -$7.46 M(-203.5%) | $1.02 M(-80.4%) |
| Dec 2011 | $5.05 M | $7.21 M(-397.6%) | $5.20 M(-133.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | -$2.42 M(-165.6%) | -$15.48 M(+16.9%) |
| June 2011 | - | $3.70 M(-212.5%) | -$13.23 M(-5.8%) |
| Mar 2011 | - | -$3.28 M(-75.6%) | -$14.05 M(+15.9%) |
| Dec 2010 | -$12.13 M(-128.8%) | -$13.46 M(+7313.8%) | -$12.13 M(-162.4%) |
| Sept 2010 | - | -$181.60 K(-106.3%) | $19.45 M(-39.4%) |
| June 2010 | - | $2.88 M(-311.7%) | $32.11 M(-19.7%) |
| Mar 2010 | - | -$1.36 M(-107.5%) | $39.99 M(-5.0%) |
| Dec 2009 | $42.09 M(+165.2%) | $18.11 M(+45.1%) | $42.09 M(+53.8%) |
| Sept 2009 | - | $12.48 M(+16.1%) | $27.37 M(+59.1%) |
| June 2009 | - | $10.75 M(+1353.9%) | $17.20 M(+27.6%) |
| Mar 2009 | - | $739.50 K(-78.2%) | $13.48 M(-15.3%) |
| Dec 2008 | $15.87 M(+17.8%) | $3.40 M(+46.9%) | $15.92 M(+0.7%) |
| Sept 2008 | - | $2.31 M(-67.1%) | $15.81 M(-9.9%) |
| June 2008 | - | $7.03 M(+121.5%) | $17.54 M(+29.2%) |
| Mar 2008 | - | $3.17 M(-3.6%) | $13.58 M(-18.5%) |
| Dec 2007 | $13.47 M(+2963.8%) | $3.29 M(-18.5%) | $16.66 M(+627.4%) |
| Sept 2007 | - | $4.04 M(+31.7%) | $2.29 M(+9.7%) |
| June 2007 | - | $3.07 M(-50.9%) | $2.09 M(-283.6%) |
| Mar 2007 | - | $6.26 M(-156.5%) | -$1.14 M(-77.5%) |
| Dec 2006 | $439.80 K(-109.2%) | -$11.08 M(-388.5%) | -$5.05 M(+85.6%) |
| Sept 2006 | - | $3.84 M(-2578.2%) | -$2.72 M(-39.1%) |
| June 2006 | - | -$154.90 K(-106.6%) | -$4.48 M(-26.2%) |
| Mar 2006 | - | $2.34 M(-126.7%) | -$6.07 M(-14.0%) |
| Dec 2005 | -$4.80 M(-2.9%) | -$8.75 M(-519.1%) | -$7.05 M(-608.0%) |
| Sept 2005 | - | $2.09 M(-219.6%) | $1.39 M(-160.6%) |
| June 2005 | - | -$1.74 M(-229.3%) | -$2.29 M(+10.6%) |
| Mar 2005 | - | $1.35 M(-545.8%) | -$2.07 M(-8.9%) |
| Dec 2004 | -$4.95 M(+834.5%) | -$302.70 K(-81.0%) | -$2.27 M(-63.8%) |
| Sept 2004 | - | -$1.59 M(+4.3%) | -$6.28 M(+56.5%) |
| June 2004 | - | -$1.53 M(-233.2%) | -$4.01 M(+61.3%) |
| Mar 2004 | - | $1.15 M(-126.6%) | -$2.49 M(-31.5%) |
| Dec 2003 | -$529.30 K(+276.5%) | -$4.31 M(-736.8%) | -$3.63 M(-636.8%) |
| Sept 2003 | - | $677.00 K | $677.00 K |
| Apr 2002 | -$140.60 K(-65.4%) | - | - |
| Apr 2001 | -$406.80 K(+14.4%) | - | - |
| Apr 2000 | -$355.70 K(+5372.3%) | - | - |
| Apr 1999 | -$6500.00 | - | - |
FAQ
- What is Sinovac Biotech annual earnings before interest & taxes?
- What is the all time high annual EBIT for Sinovac Biotech?
- What is the all time high quarterly EBIT for Sinovac Biotech?
- What is the all time high TTM EBIT for Sinovac Biotech?
What is Sinovac Biotech annual earnings before interest & taxes?
The current annual EBIT of SVA is -$150.77 M
What is the all time high annual EBIT for Sinovac Biotech?
Sinovac Biotech all-time high annual earnings before interest & taxes is $17.65 B
What is the all time high quarterly EBIT for Sinovac Biotech?
Sinovac Biotech all-time high quarterly earnings before interest & taxes is $198.69 M
What is the all time high TTM EBIT for Sinovac Biotech?
Sinovac Biotech all-time high TTM earnings before interest & taxes is $218.07 M